AR034342A1 - Metodo de determinacion de un regimen quimioterapeutico basado en la expresion de glutationa-s-transferasa pi - Google Patents
Metodo de determinacion de un regimen quimioterapeutico basado en la expresion de glutationa-s-transferasa piInfo
- Publication number
- AR034342A1 AR034342A1 ARP020101954A ARP020101954A AR034342A1 AR 034342 A1 AR034342 A1 AR 034342A1 AR P020101954 A ARP020101954 A AR P020101954A AR P020101954 A ARP020101954 A AR P020101954A AR 034342 A1 AR034342 A1 AR 034342A1
- Authority
- AR
- Argentina
- Prior art keywords
- gst
- expression
- glutationa
- transferasa
- determination
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
- C12N9/1088—Glutathione transferase (2.5.1.18)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01018—Glutathione transferase (2.5.1.18)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente se relaciona con métodos de pronóstico que son útiles en medicina, en particular, en la quimioterapia contra el cáncer. El objetivo de la presente es proporcionar un método para la evaluación de los niveles de expresión de GST-pi en tejidos fijados o fijados y empotrados en parafina, y pronosticar la probable resistencia o sensibilidad del tumor de un paciente al tratamiento con terapias a base de platino, por examen de la cantidad de ARNm de GST-pi en las células tumorales de un paciente, y comparándola con un nivel de expresión de umbral predeterminado. Más específicamente, la presente proporciona el par de cebadores de oligonucleótidos GST-pi y métodos que comprenden su uso para la detección de los niveles de ARNm de GST-pi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/879,986 US6686155B2 (en) | 2001-06-14 | 2001-06-14 | Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034342A1 true AR034342A1 (es) | 2004-02-18 |
Family
ID=25375288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020101954A AR034342A1 (es) | 2001-06-14 | 2002-05-24 | Metodo de determinacion de un regimen quimioterapeutico basado en la expresion de glutationa-s-transferasa pi |
Country Status (15)
Country | Link |
---|---|
US (4) | US6686155B2 (es) |
EP (1) | EP1407047B1 (es) |
JP (2) | JP4303104B2 (es) |
KR (2) | KR20090060380A (es) |
CN (2) | CN100355770C (es) |
AR (1) | AR034342A1 (es) |
AU (1) | AU2002305573B2 (es) |
CA (1) | CA2450257C (es) |
ES (1) | ES2457077T3 (es) |
HK (1) | HK1070921A1 (es) |
IL (2) | IL159301A0 (es) |
MX (1) | MXPA03011632A (es) |
NZ (1) | NZ530520A (es) |
TW (1) | TWI338049B (es) |
WO (1) | WO2002103055A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040204435A1 (en) * | 2003-04-09 | 2004-10-14 | Joachim Liehr | Alternating treatment with topoisomerase I and topoisomerase II inhibitors |
CA2848463A1 (en) * | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
CA2572384A1 (en) * | 2004-07-01 | 2006-02-02 | University Of Southern California | Genetic markers for predicting disease and treatment outcome |
US20060252082A1 (en) * | 2005-05-04 | 2006-11-09 | University Of South Florida | Predicting treatment response in cancer subjects |
US20070059753A1 (en) * | 2005-09-15 | 2007-03-15 | Tatiana Vener | Detecting gene methylation |
BRPI0813364A2 (pt) * | 2007-06-15 | 2014-12-30 | Univ South Florida | Métodos de diagnóstico e tratamento de câncer. |
AU2009339802B2 (en) * | 2009-02-16 | 2014-07-24 | Atlas Antibodies Ab | RBM3 as a marker for malignant melanoma prognosis |
JP5361488B2 (ja) * | 2009-03-24 | 2013-12-04 | オリンパス株式会社 | 蛍光観察装置 |
JP5680442B2 (ja) * | 2011-02-24 | 2015-03-04 | シスメックス株式会社 | 癌細胞のタキサン系抗癌剤感受性判定方法、それを実現するためのコンピュータプログラム及び装置 |
GB201316027D0 (en) * | 2013-09-09 | 2013-10-23 | Almac Diagnostics Ltd | Molecular diagnostic test for oesophageal cancer |
CN113577290B (zh) * | 2014-12-26 | 2023-10-24 | 日东电工株式会社 | 细胞死亡诱导试剂、细胞增殖抑制试剂及用于治疗由细胞增殖异常导致的疾病的医药组合物 |
CN112321489B (zh) * | 2020-10-15 | 2022-04-19 | 中山大学 | 一种基于活性巯基和报告离子的亲电分子探针及其制备方法和应用 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4830969A (en) * | 1981-08-31 | 1989-05-16 | The Research Foundation Of State University Of New York | Process for the rapid and simple isolation of nucleic acids |
US4843155A (en) * | 1987-11-19 | 1989-06-27 | Piotr Chomczynski | Product and process for isolating RNA |
US5128247A (en) * | 1989-08-14 | 1992-07-07 | Board Of Regents, The University Of Texas System | Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources |
US5942389A (en) * | 1990-10-19 | 1999-08-24 | Board Of Trustees Of The University Of Illinois | Genes and genetic elements associated with sensitivity to cisplatin |
US5204241A (en) * | 1990-10-22 | 1993-04-20 | Oxi-Gene Inc. | Glutathione-S-transferase mu as a measure of drug resistance |
US5620852A (en) | 1990-11-14 | 1997-04-15 | Hri Research, Inc. | Nucleic acid preparation methods |
US5654179A (en) * | 1990-11-14 | 1997-08-05 | Hri Research, Inc. | Nucleic acid preparation methods |
US5284940A (en) | 1990-11-14 | 1994-02-08 | Hri Research, Inc. | Preparation for nucleic acid samples |
US5346994A (en) | 1992-01-28 | 1994-09-13 | Piotr Chomczynski | Shelf-stable product and process for isolating RNA, DNA and proteins |
US5502166A (en) * | 1992-02-26 | 1996-03-26 | Mitsubishi Chemical Corporation | NMDH receptor proteins and genes encoding the same |
JP3615545B2 (ja) | 1993-02-01 | 2005-02-02 | キアゲン・エヌ・ブイ | 第四級アンモニウム塩界面活性剤及びそのrnaの単離剤 |
US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
AU2289495A (en) | 1994-04-13 | 1995-11-10 | Uab Research Foundation, The | Dihydropyrimidine dehydrogenase compositions and methods of use |
US5643767A (en) * | 1994-05-02 | 1997-07-01 | The Rockefeller University | Process for isolating cellular components |
CA2153215A1 (en) * | 1994-07-06 | 1996-01-07 | Lu Wang | Treatment of paraffin embedded tissue for gene analysis |
US6136605A (en) * | 1994-08-26 | 2000-10-24 | Wisconsin Alumni Research Foundation | Glutathione S-transferase isoforms |
US5707802A (en) * | 1995-01-13 | 1998-01-13 | Ciba Corning Diagnostics Corp. | Nucleic acid probes for the detection and identification of fungi |
US5777099A (en) * | 1995-02-24 | 1998-07-07 | Biotecx Laboratories, Inc. | RNA separation |
US5945515A (en) * | 1995-07-31 | 1999-08-31 | Chomczynski; Piotr | Product and process for isolating DNA, RNA and proteins |
DE29601618U1 (de) * | 1996-01-31 | 1996-07-04 | Invitek Gmbh | Vorrichtung zur gleichzeitigen multiplen Isolierung |
EP0791654A1 (en) * | 1996-02-21 | 1997-08-27 | Jürgen A. Dr. Richt | Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
KR0177890B1 (ko) * | 1996-03-05 | 1999-04-01 | 이병언 | 반응특이성이 향상된 중합효소 연쇄반응용 튜브 |
WO1997035034A1 (en) | 1996-03-20 | 1997-09-25 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations |
CA2253937A1 (en) | 1996-05-10 | 1997-11-20 | Phylomed Corporation | Methods for oxidizing disulfide bonds using ozone |
US5968737A (en) * | 1996-11-12 | 1999-10-19 | The University Of Mississippi | Method of identifying inhibitors of glutathione S-transferase (GST) gene expression |
WO1998041648A2 (en) | 1997-03-20 | 1998-09-24 | Variagenics, Inc. | Target genes for allele-specific drugs |
US6248535B1 (en) | 1999-12-20 | 2001-06-19 | University Of Southern California | Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
WO2002044423A2 (en) * | 2000-12-01 | 2002-06-06 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors |
US7618793B2 (en) * | 2004-10-20 | 2009-11-17 | The Regents Of The University Of Washington | Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide |
US7618777B2 (en) * | 2005-03-16 | 2009-11-17 | Agilent Technologies, Inc. | Composition and method for array hybridization |
US7615729B2 (en) * | 2007-12-10 | 2009-11-10 | Aptina Imaging Corporation | Apparatus and method for resonant lens focusing |
-
2001
- 2001-06-14 US US09/879,986 patent/US6686155B2/en not_active Expired - Lifetime
-
2002
- 2002-05-15 JP JP2003505376A patent/JP4303104B2/ja not_active Expired - Fee Related
- 2002-05-15 IL IL15930102A patent/IL159301A0/xx unknown
- 2002-05-15 ES ES02734403.5T patent/ES2457077T3/es not_active Expired - Lifetime
- 2002-05-15 MX MXPA03011632A patent/MXPA03011632A/es active IP Right Grant
- 2002-05-15 KR KR1020097010707A patent/KR20090060380A/ko active Search and Examination
- 2002-05-15 CN CNB2005101076846A patent/CN100355770C/zh not_active Expired - Fee Related
- 2002-05-15 AU AU2002305573A patent/AU2002305573B2/en not_active Ceased
- 2002-05-15 CA CA2450257A patent/CA2450257C/en not_active Expired - Fee Related
- 2002-05-15 WO PCT/US2002/015203 patent/WO2002103055A1/en active Application Filing
- 2002-05-15 EP EP02734403.5A patent/EP1407047B1/en not_active Expired - Lifetime
- 2002-05-15 CN CNB028157982A patent/CN100494398C/zh not_active Expired - Fee Related
- 2002-05-15 NZ NZ530520A patent/NZ530520A/en not_active IP Right Cessation
- 2002-05-24 AR ARP020101954A patent/AR034342A1/es not_active Application Discontinuation
- 2002-05-28 TW TW091111310A patent/TWI338049B/zh not_active IP Right Cessation
-
2003
- 2003-09-03 US US10/653,387 patent/US20050074775A1/en not_active Abandoned
- 2003-09-04 US US10/654,575 patent/US7138507B2/en not_active Expired - Lifetime
- 2003-09-04 US US10/654,576 patent/US20040241705A1/en not_active Abandoned
- 2003-12-10 IL IL159301A patent/IL159301A/en not_active IP Right Cessation
- 2003-12-13 KR KR1020037016349A patent/KR100918927B1/ko not_active IP Right Cessation
-
2005
- 2005-04-25 HK HK05103515.5A patent/HK1070921A1/xx not_active IP Right Cessation
-
2008
- 2008-07-07 JP JP2008177217A patent/JP4308309B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL159301A (en) | 2010-06-16 |
JP2009000118A (ja) | 2009-01-08 |
EP1407047A4 (en) | 2005-03-30 |
CN100494398C (zh) | 2009-06-03 |
CA2450257C (en) | 2012-11-06 |
US6686155B2 (en) | 2004-02-03 |
HK1070921A1 (en) | 2005-06-30 |
EP1407047B1 (en) | 2014-01-22 |
CA2450257A1 (en) | 2002-12-27 |
NZ530520A (en) | 2006-10-27 |
IL159301A0 (en) | 2004-06-01 |
CN100355770C (zh) | 2007-12-19 |
AU2002305573B2 (en) | 2009-01-08 |
US20020197609A1 (en) | 2002-12-26 |
KR20090060380A (ko) | 2009-06-11 |
KR20040018269A (ko) | 2004-03-02 |
CN1763064A (zh) | 2006-04-26 |
MXPA03011632A (es) | 2005-04-19 |
TWI338049B (en) | 2011-03-01 |
JP4303104B2 (ja) | 2009-07-29 |
ES2457077T3 (es) | 2014-04-24 |
JP2004530434A (ja) | 2004-10-07 |
US7138507B2 (en) | 2006-11-21 |
US20050019783A1 (en) | 2005-01-27 |
US20040241705A1 (en) | 2004-12-02 |
JP4308309B2 (ja) | 2009-08-05 |
WO2002103055A1 (en) | 2002-12-27 |
EP1407047A1 (en) | 2004-04-14 |
CN1541277A (zh) | 2004-10-27 |
US20050074775A1 (en) | 2005-04-07 |
KR100918927B1 (ko) | 2009-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR031442A1 (es) | Metodo para determinar un regimen quimioterapeutico basado en la expresion de ercc1 y ts | |
AR031455A1 (es) | Metodo para determinar un regimen quimioterapeutico basado en la expresion de ercc1 | |
AR031443A1 (es) | Metodo de determinacion de la expresion genetica de receptor de factor de crecimiento epidermico y her2-neu y correlacion de los niveles de los mismos con los indices de supervivencia | |
AR032917A1 (es) | Metodo para determinar la expresion de genes de dihidropirimidina deshidrogenasa | |
HK1070921A1 (en) | Method for determining the expression level of glutathione-s-transferase pi | |
Ju et al. | Expression and clinical implication of Beclin1, HMGB1, p62, survivin, BRCA1 and ERCC1 in epithelial ovarian tumor tissues. | |
Devis et al. | Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early‐stage endometrioid endometrial cancer | |
MX2010005081A (es) | Metodo para determinar la probabilidad de una respuesta terapeutica en la quimioterapia para el cancer con un glicosido cardiaco. | |
Chen et al. | Role of the stem cell-associated intermediate filament nestin in malignant proliferation of non-small cell lung cancer | |
Li et al. | Circulating microRNA-137 is a potential biomarker for human glioblastoma. | |
Li et al. | Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue | |
Cai et al. | CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma | |
Okami et al. | Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe | |
Mccarthy et al. | Triple‐negative breast cancer: making the most of a misnomer | |
Apanovich et al. | Expression Profiles of Genes—Potential Therapy Targets—and Their Relationship to Survival in Renal Cell Carcinoma | |
Liang et al. | Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer | |
Leapman et al. | Haematuria after prostate brachytherapy. | |
Takahara et al. | Insulin-like growth factor-binding protein-5 (IGFBP5) supports prostate cancer cell proliferation | |
Wu et al. | Survival analysis of lymphoepithelioma-like carcinoma of the urinary bladder and the effect of surgical treatment modalities on prognosis | |
US11002740B2 (en) | Methods of detecting and reducing cancer cell central nervous system colonization | |
Lekakis et al. | Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it? | |
Xi et al. | Proposed modification of the pN2 classification of the 8th edition AJCC staging system for esophageal squamous cell carcinoma: a preliminary study based on the Chinese population | |
Visentin et al. | P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma | |
Margaritopoulos et al. | Yin Yang-1 (YY-1) expression in idiopathic pulmonary fibrosis | |
Blanco et al. | Exploratory study of CK-M30 and pHH3 expression in Circulating Tumor Cells (CTCs) as biomarkers of docetaxel (DOC) efficacy in metastatic castration resistant prostate cancer (mCRPC) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed, e.g., due to non-payment of fee |